An Evaluation of the Pharmacokinetics of a Single Oral Dose of GSK189075 in Patients With Varying Degrees of Renal Insufficiency Compared to Volunteers With Normal Renal Function.
Phase of Trial: Phase I
Latest Information Update: 01 May 2015
At a glance
- Drugs Remogliflozin etabonate (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 23 Jun 2008 Status change
- 11 Aug 2007 New trial record.